| Authors: |
Croce CM; Department of Cancer Biology and Genetics and Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA. Carlo.Croce@osumc.edu., Tait SWG; Cancer Research UK Scotland Institute, Glasgow, UK. Stephen.Tait@glasgow.ac.uk.; School of Cancer Sciences, University of Glasgow, Glasgow, UK. Stephen.Tait@glasgow.ac.uk., Garcia-Sáez AJ; Max Planck Institute of Biophysics, Frankfurt am Main, Germany. ana.garcia@biophys.mpg.de.; Institute of Genetics, CECAD, University of Cologne, Cologne, Germany. ana.garcia@biophys.mpg.de., Villunger A; Institute for Developmental Immunology, Biocenter, Medical University of Innsbruck, Innsbruck, Austria. andreas.villunger@i-med.ac.at.; CeMM, Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria. andreas.villunger@i-med.ac.at., Letai A; Dana-Farber Cancer Institute, Harvard University, Cambridge, MA, USA. anthony_letai@dfci.harvard.edu., Walter HS; The Ernest and Helen Scott Haematological Research Institute, Department of Genetics, Genomics and Cancer Sciences, University of Leicester, Leicester, UK. hw191@le.ac.uk., Dyer MJS; The Ernest and Helen Scott Haematological Research Institute, Department of Genetics, Genomics and Cancer Sciences, University of Leicester, Leicester, UK. mjsd1@le.ac.uk., Green DR; Department of Immunology, St Jude Children's Research Hospital, Memphis, TN, USA. douglas.green@stjude.org., Shi Y; The Fourth Affiliated Hospital of Soochow University, Institutes for Translational Medicine, State Key Laboratory of Radiation Medicine and Protection, Suzhou Medical College Soochow University, Suzhou, China. yfshi@suda.edu.cn., Melino G; Department of Experimental Medicine, TOR, University of Rome Tor Vergata, Rome, Italy. melino@uniroma2.it. |
